Mar 20, 2023 8:00am EDT IceCure Medical to Report 2022 Full Year Financial & Operational Results on March 29, 2023
Feb 09, 2023 8:00am EST IceCure Medical Announces Preliminary Unaudited 2022 Year-End Financial Results & Recent Operational Highlights
Jan 26, 2023 8:00am EST IceCure's ProSense Featured in Breast Session at the Society of Interventional Oncology's Annual Scientific Meeting in Washington, D.C.
Jan 25, 2023 8:00am EST IceCure's ProSense Presented in Hands-On Training Course at The American Society of Breast Surgeons Breast Follows Ultrasound Course
Jan 23, 2023 8:00am EST U.S. Patent Office Grants Notice of Allowance to IceCure for Novel Cryogenic Pump for Next-Generation Cryoablation Systems
Jan 18, 2023 8:00am EST IceCure Receives Notice of Patent Allowance in Japan for a Novel Cryogenic Pump for its Next-Generation Cryoablation Systems
Dec 23, 2022 4:00pm EST IceCure Medical Ltd. Announces Closing of $14.5 Million Public Offering Priced At-The-Market Under Nasdaq Rules
Dec 21, 2022 9:00am EST IceCure Medical Ltd. Announces Pricing of $14.5 Million Public Offering Priced At-The-Market Under Nasdaq Rules
